• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NURSE ASSIST, INC. NURSE ASSIST; NORMAL SALINE FLUSH SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NURSE ASSIST, INC. NURSE ASSIST; NORMAL SALINE FLUSH SYRINGE Back to Search Results
Model Number 1210-BP
Medical Device Problem Code Appropriate Device Problem Term/Code Not Available (3191)
Health Effect - Clinical Code Bacterial Infection (1735)
Date of Event 12/21/2016
Type of Reportable Event Death
Additional Manufacturer Narrative
Nurse assist saline flush syringes are single-use devices.The company does not know if the products were reprocessed or reused on patients.No used syringes were returned to the manufacturer.Manufacturer tested retained samples for bioburden, and there was no presence of b.Cepacia in those samples.Sterility testing on retained samples confirmed that there was no growth in the product.On (b)(6) 2016, the (b)(4) department of health (padoh) informed nurse assist that syringes from lot number 1607418 tested positive for b.Cepacia.Padoh sent the manufacturer unused syringes from one of the affected facilities for testing.The testing confirmed that the syringes distributed by pharmscript, llc (lot #: 1607418) contain burkholderia multivorans (a sub species of the burkholderia cepacia complex).Lot # 1607418 was not distributed to any other customers by the manufacturer.(b)(4).Nurse assist initiated a voluntary recall for all lots of saline flush syringes.The removal was initiated on (b)(6) 2016.Device not returned to manufacturer.
 
Event or Problem Description
On (b)(6) 2016, the centers for disease control (cdc) website noted 3 additional infection cases (yielding b.Cepacia in a patient who between (b)(6) 2016 and the present ((b)(6) 2016) received intravenous care at a facility that was utilizing prefilled 0.9% sodium chloride iv flush solution manufactured by nurse assist) and one additional death associated with the b.Cepacia infections previously reported by nurse assist (see mdr reports: 1650927-2016-00001 through 1650927-2016-00018).According to the cdc, it is not known whether the death was the result of the infection or of another underlying cause.Despite efforts, manufacturer has been unable to obtain further information about the reported events.Because of this, and based on guidance from the fda, nurse assist is treating these reports as a literature source.No information is known about the specific cases or patients, thus a single mdr report will be filed for each cdc report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NURSE ASSIST
Common Device Name
NORMAL SALINE FLUSH SYRINGE
Manufacturer (Section D)
NURSE ASSIST, INC.
4409 haltom rd.
haltom city TX 76117
MDR Report Key6214768
Report Number1650927-2016-00019
Device Sequence Number741647
Product Code NGT
UDI-Device Identifier0+B1501210BP0C
UDI-Public+B1501210BP0C
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
K150143
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source literature
Initial Reporter Occupation Other
Remedial Action Recall
Type of Report Initial
Report Date (Section B) 12/29/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2018
Device Model Number1210-BP
Device Catalogue Number1210-BP
Device Lot Number1607418
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/21/2016
Initial Report FDA Received Date12/29/2016
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
1650927-10/14/2016-001-R
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-